Cardioembolic strokes in Eastern Iran and the importance of rheumatic valvular disease

Turkish Journal of Medical Sciences

Volumn 36, Issue 6, 2006, Pages 361-364

  Ghandehari, Kavian ^a,c   Izadi Mood, Zahra ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BIRJAND UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cardioembolic; Rheumatic; Stroke

Indexed keywords

CARDIOLOGY; DIAGNOSIS; HEALTH CARE; INTERNATIONAL COOPERATION; PATIENT MONITORING;

ANTICOAGULATION; CARDIOEMBOLIC STROKES; ETIOLOGY; RHEUMATIC VALVULAR DISEASE; WORLD HEALTH ORGANIZATION (WHO);

DISEASE CONTROL;

ANTICOAGULANT AGENT;

ADULT; AGED; ANTICOAGULATION; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE STENOSIS; RHEUMATIC HEART DISEASE; STROKE; TERTIARY HEALTH CARE; WORLD HEALTH ORGANIZATION;

EID: 33845715112     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Hyder S, Usman A, Khan S, Seyed NA, Ahmed N. Stroke subtypes in Pakistan population. Neurology 1995; 45(4): 189.
2. Venketasubramanian N. Stroke in developing countries. In: Fisher M, Bogousslavsky J, editors. Current Review of Cerebrovascular Disease. 3rd edition. Philadelphia: Current Medicine; 2001. pp. 212-214.
3. Abernathy WS, Willis PW. Thromboembolic complications of rheumatic heart disease. Cardiovasc Clin 1973; 5: 131-175.
4. WHO MONICA Project Principal Investigators. The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol 1988; 41: 105-114.
5. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicentre clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 1993; 24(1): 35-41.
6. Foulkes MA, Wolf PA, Price TR, Mohr JP, Hier DB. The Stroke Data Bank: design, methods and baseline characteristics. Stroke 1988; 19: 547-554.
7. Bogousslavsky J, Van Melle G, Regli F. The Lausanne Stroke Registry: analysis of 1000 consecutive patients with first stroke. Stroke 1988; 19: 1083-1992.
8. Hart RG, Halperin JL. Atrial fibrillation and stroke: concepts and controversies. Stroke 2001; 32: 803-808.
9. Braunwald E. Valvular heart disease. In: Braunwald E, Douglas PZ, Peter L, editors. Heart Disease. 6th ed. Vol 2. Philadelphia: W.B.Saunders Co; 2001. pp. 1643-1693.
10. Ghandehari K, Izadi Moud Z. Incidence and etiology of ischemic stroke in Persian young adults. Acta Neurol Scand 2006; 113: 121-124.
11. Dare AJ, Veinot JP, Edward WD. New observations in the etiology of aortic valve disease. Hum Path 1993; 24: 1330.
12. Zenebe G, Alemayehu M, Asmera J. Characteristics and outcome of stroke at Tikur Anbessa teaching hospital, Ethiopia. Ethiop Med J 2005; 43: 251-259.
13. Ghandehari K, Izadi Z. The Khorasan stroke registry: results of a five-year hospital-based study. Cerebrovasc Dis 2007; 23: 132-139.
14. Zoghbi WA, Nagueh SF. Valvular heart disease. In: Wilansky S, Willerson JT, editors. Heart Disease in Women. London: Churchill Livingston; 2002. pp. 241-256.
15. Chiang CW, Kuo CT, Chen WJ. Comparisons between female and male patients with mitral stenosis. Br Heart J 1994; 72: 567-570.
16. Hart RG. Antithrombotic therapies for stroke prevention in atrial fibrillation. In: Barnett HJM, Bogousslavsky J, Meldrum H, editors. Ischemic Stroke: Advances in Neurology. Vol.99. Philadelphia: Lippincott Williams and Wilkins; 2003. p. 203.
17. Hinchey JA, Furlan AJ, Barnett HJM. Cardiogenic brain embolism: incidence, varieties and treatment. In: Barnett HJM, Mohr JP, Stein BM, Yatsu FM, editors. Stroke, Pathophysiology, Diagnosis and Management. 4th edition. Philadelphia: Churchill Livingstone; 2004. pp. 1089-1110.